RF
44
10
NWS
69
5
FOX
71
3
NTRS
35
10
AFL
34
6
MS
64
3
STZ
42
2
INTC
35
4
MO
47
6
DG
14
6
CAT
47
3
VFC
56
6
GILD
55
5
GS
65
16
ORLY
48
3
FITB
36
3
DRI
74
5
KSS
36
2
EMR
57
7
GME
61
2
RF
44
10
NWS
69
5
FOX
71
3
NTRS
35
10
AFL
34
6
MS
64
3
STZ
42
2
INTC
35
4
MO
47
6
DG
14
6
CAT
47
3
VFC
56
6
GILD
55
5
GS
65
16
ORLY
48
3
FITB
36
3
DRI
74
5
KSS
36
2
EMR
57
7
GME
61
2
Financhill
Back

Thomson Reuters Vs. Kymera Therapeutics Industry Stock Comparison

Sell
38

TRI.TO
Thomson Reuters

Last Price:
$234.53
Seasonality Move:
3.12%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.75
Seasonality Move:
2.79%
Sell
38
Thomson Reuters (TRI.TO) is a Sell

Is Thomson Reuters a Buy, Sell or Hold?

  • The current Thomson Reuters [TRI.TO] share price is $233.16. The Score for TRI.TO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • TRI.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.64. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRI.TO Stock Price Chart

What is Thomson Reuters's stock price today?

  • The Thomson Reuters share price today is $233.16
    The current trend is moderately bearish and TRI.TO is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRI.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.58 Buy
Relative Strength Index (14 RSI): 47.01 Sell
Chaikin Money Flow: -485606 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (226.55 - 238.89) Buy
Bollinger Bands (100): (224.69 - 235.09) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.07 Sell
Chaikin Money Flow: 1023886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.59 - 46.41) Sell
Bollinger Bands (100): (42.92 - 48.78) Sell

TRI.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 237.43 Sell
20-day SMA: 234.59 Sell
50-day SMA: 232.34 Buy
200-day SMA: 226.13 Buy
8-day EMA: 236.26 Sell
20-day EMA: 235.22 Sell
50-day EMA: 232.86 Buy
200-day EMA: 223.37 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.68 Sell
20-day SMA: 44.26 Sell
50-day SMA: 45.89 Sell
200-day SMA: 41.31 Sell
8-day EMA: 41.51 Sell
20-day EMA: 43.39 Sell
50-day EMA: 44.87 Sell
200-day EMA: 41.09 Sell

Thomson Reuters Earnings Growth & TRI.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.44 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Thomson Reuters Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):